Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended	9 Months Ended
Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Revenues	$ 39,353	$ 23,881	$ 103,611	$ 74,241
Cost of revenues	29,369	23,364	78,759	69,533
Gross margin	9,984	517	24,852	4,708
Operating expenses:
Research and development	2,199	2,083	5,693	7,076
Selling, general and administrative	7,833	7,173	23,648	22,084
Amortization of acquisition-related intangibles	538	690	1,614	2,058
Change in fair value of contingent consideration	852	(220)	3,052	(340)
Restructuring	0	0	(14)	0
Total operating expenses	11,422	9,726	33,993	30,878
Operating loss	(1,438)	(9,209)	(9,141)	(26,170)
Interest income, net	150	42	518	112
China dissolution	0	0	0	(1,921)
Other expense, net	(298)	(287)	(618)	(48)
Loss before income tax expense	(1,586)	(9,454)	(9,241)	(28,027)
Income tax expense	63	127	291	144
Net loss	$ (1,649)	$ (9,581)	$ (9,532)	$ (28,171)
Net loss per common share
Basic (in dollars per share)	$ (0.06)	$ (0.34)	$ (0.33)	$ (1.01)
Diluted (in dollars per share)	$ (0.06)	$ (0.34)	$ (0.33)	$ (1.01)
Weighted average number of common shares outstanding
Basic (in shares)	29,092	27,954	28,728	27,794
Diluted (in shares)	29,092	27,954	28,728	27,794

The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.

Name:	us-gaap_AmortizationOfAcquisitionCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.